SCHEMBL29896987

SCHEMBL29896987

CC(=C(C#N)C(N)=O)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.50
GABRG2 P18507 3/20 0.50
GABRB3 P28472 3/20 0.50
GABRB2 P47870 2/20 0.50
ALDH1A1 P00352 4/20 0.49
RAB9A P51151 3/20 0.49
MAPT P10636 2/20 0.49
MAPK1 P28482 2/20 0.49
LMNA P02545 2/20 0.49
XBP1 P17861 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MAPK10 P53779 2/20 0.44
TP53 P04637 1/20 0.44
TSHR P16473 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
POLB P06746 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP3A4 P08684 1/20 0.43
PARP1 P09874 1/20 0.43
RECQL P46063 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2566020 0.85 ALDH1A1 (0.51) ALDH1A1RAB9AMAPTMAPK1LMNA
SCHEMBL2566022 0.85 ALDH1A1 (0.51) ALDH1A1RAB9AMAPTMAPK1LMNA
SCHEMBL3289274 0.85 ALDH1A1 (0.51) ALDH1A1RAB9AMAPTMAPK1LMNA
SCHEMBL28420371 0.85 ALDH1A1 (0.51) ALDH1A1RAB9AMAPTMAPK1LMNA
SCHEMBL8307774 0.84 GABRA1 (0.49) GABRA1GABRG2GABRB3GABRB2ALDH1A1
SCHEMBL28892760 0.83 ALDH1A1 (0.64) ALDH1A1RAB9AMAPTMAPK1LMNA
SCHEMBL1876606 0.81 ALDH1A1 (0.41) ALDH1A1RAB9AMAPTMAPK1LMNA
SCHEMBL8234794 0.81 ALDH1A1 (0.41) ALDH1A1RAB9AMAPTMAPK1LMNA
SCHEMBL1876605 0.81 ALDH1A1 (0.41) ALDH1A1RAB9AMAPTMAPK1LMNA
SCHEMBL548316 0.81 ALDH1A1 (0.47) GABRA1GABRG2GABRB3GABRB2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4051266-A1 4-AMINOBUT-2-ENAMIDE DERIVATIVES AND SALTS THEREOF Taiho Pharmaceutical Co., Ltd. (JP) 2022-09-07 EP disclosed